Efficacy and safety of finerenone in patients with CKD and type 2 diabetes across the frailty spectrum: a FIDELITY post hoc analysis

被引：0
|
作者：
Rossing, P. [1 ,2 ]
Birkenfeld, A. [3 ,4 ]
Fioretto, P. [5 ]
McGill, J. B. [6 ]
Anker, S. D. [7 ,8 ]
Pitt, B. [9 ]
Scalise, A. [10 ]
Scott, C. [11 ]
Filippatos, G. [12 ]
机构：
[1] Steno Diabet Ctr Copenhagen, Herlev, Denmark
[2] Univ Copenhagen, Copenhagen, Denmark
[3] Univ Clin, Tubingen, Germany
[4] German Ctr Diabet Res, Neuherberg, Germany
[5] Univ Padua, Dept Med, Padua, Italy
[6] Washington Univ, Sch Med, St Louis, MO USA
[7] Charite, Berlin, Germany
[8] Wroclaw Med Univ, Wroclaw, Poland
[9] Univ Michigan, Sch Med, Ann Arbor, MI USA
[10] Bayer Hispania SL, Barcelona, Spain
[11] Bayer PLC, Reading, Berks, England
[12] Natl & Kapodistrian Univ Athens, Athens, Greece
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
892
引用
收藏
页码：S426 / S427
页数：2
相关论文
共 50 条
  • [41] Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis
    Hiren Patel
    Kashif Munir
    Sindee Sutherland
    Chrisanthi A. Karanikas
    Manige Konig
    Diabetes Therapy, 2019, 10 : 2321 - 2330
  • [42] Finerenone in Mild to Severe Chronic Kidney Disease and Type 2 Diabetes: A FIDELITY Subgroup Analysis in Patients With Heart Failure
    Filippatos, Gerasimos
    Agarwal, Rajiv
    Anker, Stefan D.
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Lambelet, Marc
    Ruilope, Luis M.
    Bakris, George L.
    Pitt, Bertram
    CIRCULATION, 2021, 144 (25) : E582 - E582
  • [43] Finerenone in Mild to Severe Chronic Kidney Disease and Type 2 Diabetes: A Fidelity Subgroup Analysis in Patients with Heart Failure
    Filippatos, Gerasimos
    Agarwal, Rajiv
    Anker, Stefan D.
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Lambelet, Marc
    Viaud, Marco A. L.
    Ruilope, Luis M.
    Bakris, George L.
    Pitt, Bertram
    AMERICAN HEART JOURNAL, 2022, 254 : 254 - 254
  • [44] Finerenone and Kidney Outcomes in Patients with CKD and Type 2 Diabetes: Results from FIGARO-DKD
    Bakris, George L.
    Ruilope, Luis M.
    Rossing, Peter
    Anker, Stefan D.
    Pitt, Bertram
    Filippatos, Gerasimos
    Mentenich, Nicole
    Lage, Andrea Z.
    Scheerer, Markus
    Joseph, Amer
    Agarwal, Rajiv
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 45 - 45
  • [45] A Systematic Review and Meta-Analysis on the Efficacy and Safety of Finerenone Therapy in Patients with Cardiovascular and Chronic Kidney Diseases in Type 2 Diabetes Mellitus
    Jyotsna, F. N. U.
    Mahfooz, Kamran
    Patel, Tirath
    Parshant, F. N. U.
    Simran, Fnu
    Harsha, Fnu
    Neha, Fnu
    Jyotishna, Dev
    Mishra, Dipesh
    Subedi, Sirjana
    Khatri, Mahima
    Kumar, Satesh
    Varrassi, Giustino
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [46] Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies
    Kuang, Jian
    Zhu, Jiankun
    Liu, Siying
    Li, Quanmin
    DIABETES THERAPY, 2020, 11 (10) : 2329 - 2339
  • [47] Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study
    Shinichi Umezawa
    Akira Kubota
    Hajime Maeda
    Akira Kanamori
    Kiyokazu Matoba
    Yasuyuki Jin
    Fuyuki Minagawa
    Mitsuo Obana
    Kotaro Iemitsu
    Shogo Ito
    Hikaru Amamiya
    Mizuki Kaneshiro
    Masahiko Takai
    Hideaki Kaneshige
    Kazuhiko Hoshino
    Masashi Ishikawa
    Nobuaki Minami
    Tetsuro Takuma
    Nobuo Sasai
    Sachio Aoyagi
    Takehiro Kawata
    Atsuko Mokubo
    Yukiko Miyairi
    Hiroshi Takeda
    Shin Honda
    Hideo Machimura
    Tetsuya Motomiya
    Manabu Waseda
    Yoshikazu Naka
    Yasushi Tanaka
    Yasuo Terauchi
    Ikuro Matsuba
    BMC Endocrine Disorders, 15
  • [48] Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A post hoc subgroup analysis of the PIONEER 1, 3, 4 and 8 trials
    Araki, Eiichi
    Terauchi, Yasuo
    Watada, Hirotaka
    Deenadayalan, Srikanth
    Christiansen, Erik
    Horio, Hiroshi
    Kadowaki, Takashi
    DIABETES OBESITY & METABOLISM, 2021, 23 (12): : 2785 - 2794
  • [49] Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study
    Umezawa, Shinichi
    Kubota, Akira
    Maeda, Hajime
    Kanamori, Akira
    Matoba, Kiyokazu
    Jin, Yasuyuki
    Minagawa, Fuyuki
    Obana, Mitsuo
    Iemitsu, Kotaro
    Ito, Shogo
    Amamiya, Hikaru
    Kaneshiro, Mizuki
    Takai, Masahiko
    Kaneshige, Hideaki
    Hoshino, Kazuhiko
    Ishikawa, Masashi
    Minami, Nobuaki
    Takuma, Tetsuro
    Sasai, Nobuo
    Aoyagi, Sachio
    Kawata, Takehiro
    Mokubo, Atsuko
    Miyairi, Yukiko
    Takeda, Hiroshi
    Honda, Shin
    Machimura, Hideo
    Motomiya, Tetsuya
    Waseda, Manabu
    Naka, Yoshikazu
    Tanaka, Yasushi
    Terauchi, Yasuo
    Matsuba, Ikuro
    BMC ENDOCRINE DISORDERS, 2015, 15
  • [50] Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: a post hoc analysis of pooled data
    Davies, Michael J.
    Merton, Katherine
    Vijapurkar, Ujjwala
    Yee, Jacqueline
    Qiu, Rong
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
12345